Medical consultation platform developer Ubie has received $18.4m from medicine distributor Suzuken that will be used to enhance its apps, increase headcount and expand internationally.
Pharmaceutical wholesaler Suzuken provided ¥2bn ($18.4m) in funding yesterday for Ubie, the Japan-based developer of an intelligent medical consultation service.
Founded in 2017, Ubie provides artificial intelligence-powered consultation service for health facilities. Its products included AI-based symptom checker apps AI Monshin Ubie and Dr Ubie which help patients self-triage, allowing time for care professionals to prepare in advance of their arrival.
Suzuken intends to mobilise a sales network located in 240 branches across 47 Japanese administrative divisions in order to…
